Makes life-sciences tools and quality-control products and services for pharmaceutical, healthcare and medical-device companies, research labs, hospitals and dental offices.
10-K for FY2026, filed Jun 3, 2026We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated…View ↗
Our Sterilization and Disinfection Control division manufactures and sells biological, chemical and cleaning indicators used to assess the…View ↗
Our Clinical Genomics division develops, manufactures and sells highly sensitive high-throughput genetic analysis instruments, consumables…View ↗
Our Biopharmaceutical Development division develops, manufactures, sells and services automated systems for protein analysis (immunoassays)…View ↗
Our Calibration Solutions division develops, manufactures, sells and services quality control products using principles of advanced…View ↗
Customers buy consumables and hardware, generally paid for when shipped in the United States and APAC or delivered in Europe. They also pay for completed testing, calibration and maintenance work, or for ongoing service contracts over the contract term; payment is typically due within 60 days or less.
10-K for FY2026, filed Jun 3, 2026Our revenues are derived from sales of products and services. Product sales consist primarily of consumables and hardware, while services…View ↗
Product sales: Our performance obligations related to product sales generally consist of the promise to sell tangible goods to distributors…View ↗
Services: We generate service revenues from discrete and ongoing maintenance, calibration and testing services related to our physical…View ↗
Purchase orders or formal contracts typically provide evidence of the existence and key terms of arrangements with customers with respect…View ↗
10-K for FY2026, filed Jun 3, 2026
FY2026 revenue by product or service ↗$249.1M
10-K for FY2026, filed Jun 3, 2026
$249.1M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2026, filed Jun 3, 2026 |
82%
FY2023: 82%
|
Product, FY2026
$203.4M Sources
|
Sold outright |
|
Service
|
18%
FY2023: 18%
|
Service, FY2026
$45.7M Sources
|
Pharmaceutical and medical-device manufacturers, hospitals, dental offices, clinical research labs and contract research organizations buy products and services through Mesa’s sales staff and independent distributors. Some sales are made directly to customers.
10-K for FY2026, filed Jun 3, 2026Our facilities in Bozeman, Montana and in Waldems, Germany and Munich, Germany manufacture our Sterilization and Disinfection Control…View ↗
Clinical Genomics products and services are sold primarily to clinical research labs and contract research organizations, including…View ↗
Clinical Genomics products are manufactured in San Diego, California. Clinical Genomics generates revenues through direct sales personnel…View ↗
Our Calibration Solutions products are represented largely by the DialyGuard®, DryCal®, DataTrace®, and ViewPoint® brands, and are…View ↗
Yes. It kept 3 cents of every revenue dollar as net income in FY2026 and turned 16 cents into free cash flow.
8-K, filed Oct 13, 2026
The Restructuring Program includes the elimination of approximately 40 positions, primarily in our Clinical Genomics division, with…View ↗
Growing. Revenue grew 35% in 4 years, from $184.3M in FY2022 to $249.1M in FY2026, about 8% a year.
Loading...